Financial GuidanceThe latest financial guidance charts a path to profitability, driven principally by European and Canadian market uptake of its marketed anti-insomnia medication daridorexant.
Global ExpansionGlobal expansion of QUVIVIQ continues, as Simcere is in the process of introducing the product in China, opening an additional royalty stream for Idorsia.
Regulatory ApprovalAprocitentan is approved in Europe and the United Kingdom under the trade name JERAYGO and in the United States under the trade name TRYVIO™, indicating broad regulatory acceptance.